Does detoxification reverse the acute lung injury of crack smokers?

Nucl Med Commun. 1996 Nov;17(11):963-70. doi: 10.1097/00006231-199611000-00007.

Abstract

The effect on chronic crack users of a 3 month detoxification programme on lung clearance of inhaled 99Tcm-diethylenetriamine pentaacetate (99Tcm-DTPA) aerosol, spirometry and gas exchange was determined in a controlled in-patient clinical treatment setting. Imaging studies were carried out in eight chronic crack users (four crack-only and four crack plus tobacco) before and after the successful completion of the detoxification programme to measure the clearance of inhaled 99Tcm-DTPA from the lungs, an index of lung epithelial permeability. 99Tcm-DTPA lung clearance, expressed in terms of the biological half-time, T1/2, was determined from the slopes of the least-squares fit regression lines of the respective time-activity plots. The mean (+/- S.D.) global T1/2 values of the crack-only (75 +/- 39 min) and crack plus tobacco users (22 +/- 10 min) were significantly shorter (P < 0.02 and P < 0.001, respectively) than from the lungs of the non-smoking controls (124 +/- 29 min). This was consistent with increased lung epithelial permeability secondary to crack-related lung injury. The mean global T1/2 value of the crack plus tobacco users was significantly shorter (P < 0.05) than that of the crack-only users. After detoxification, the abnormally rapid lung clearance became normal in two of the four crack-only users studied, improved in a third and remained unchanged in the fourth, a subject whose T1/2 value was already normal initially. However, lung clearance improved in only one of the four crack plus tobacco users studied. Faster 99Tcm-DTPA clearance was the only impairment found in seven of the eight crack users, the eighth having restrictive lung disease. Crack-related lung injury, reflected by abnormally rapid 99Tcm-DTPA lung clearance, may be at least partially reversible after a 3 month period of abstinence from crack.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Carbon Dioxide / blood
  • Crack Cocaine*
  • Forced Expiratory Volume
  • Humans
  • Lung / diagnostic imaging*
  • Lung / physiopathology*
  • Metabolic Clearance Rate
  • Opioid-Related Disorders / complications
  • Opioid-Related Disorders / rehabilitation*
  • Oxygen / blood
  • Radionuclide Imaging
  • Smoking
  • Spirometry / methods
  • Technetium Tc 99m Pentetate* / pharmacokinetics
  • Time Factors
  • Tobacco Use Disorder / complications
  • Tobacco Use Disorder / rehabilitation*
  • Vital Capacity

Substances

  • Crack Cocaine
  • Carbon Dioxide
  • Oxygen
  • Technetium Tc 99m Pentetate